Site icon The Indian Wire

Accel Partners, Chiratae Ventures, Dream incubator invest $7 million in cancer care platform Onco


The top notch investment firms such as Accel Partners, Chiratae Ventures, and Dream Incubator, have led a series A funding round of $7 million (approx ₹49 crore) in cancer care platform Onco, through which the startup aims to be a one-stop shop for all cancer-related needs of patients and caregivers, cited Yourstory.

Also, with the infused funds, Onco plans to expand its customer base and scale operations globally.

Rashie Jain, CEO and co-founder, Onco, said, “We are solving a critical problem, that of ‘information gap’ that every cancer patient and their family experiences. There are three million cancer patients getting treated in India alone and around seven million cancer patients across Middle East, Africa, and Asia, where our services are available presently.”

Onco was founded by Rashie Jain and Dr. Amit K. Jotwani in 2016. The platform Onco, currently, offers treatment advice and care management to cancer patients across 18 countries. It has a network of over 1,500 oncologists, has over 500 hospitals and labs, and also allows patients to get personalised advice.

The platform Onco also manages the patient’s end-to-end care by connecting them with the relevant treatment centres, doctors, and labs.

Onco handles around 10,000 unique cancer cases month on month across different geographies. It also offers complimentary treatment advice to children under 14 years. Until now, the company has assisted over 100 children with cancer.

Jain further said that a significant number of patients struggled to get the right treatment advice or find the right doctors or hospitals as there currently aren’t many credible sources of information that guide the patients to the right treatment plan, doctors, and hospitals.

Ranjith Menon, Executive Director, Chiratae Ventures, said “Cancer is a global challenge. India alone adds more than a million patients every year. We are excited to see developing into a vertical platform that brings all the various stakeholders like patients, clinicians, care providers, and diagnostics.”

Barath Shankar Subramanian, Partner, Accel India, said, “It has been an incredibly fulfilling journey to see grow from a concept to a clinically recognised technology cancer care platform that offers full-stack support to cancer patients and caregivers in India and emerging markets. Given the hugely increasing cancer disease burden and severely skewed oncologists-to-patient ratio in the country, we believe that there is tremendous work to be done in cancer care delivery. It is clear to us that the best way for effective healthcare to progress is by building awareness, collaborations and communities on a patient-centric and network aggregated business model, which does holistically.”

Exit mobile version